메뉴 건너뛰기




Volumn 72, Issue FEB., 1999, Pages 121-125

Patients leaving hospital after administration of radioactive substances

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT;

EID: 0033043302     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.72.854.10365059     Document Type: Review
Times cited : (20)

References (12)
  • 5
    • 0013618228 scopus 로고
    • Medical exposure; guidance on the 1990 recommendations of ICRP
    • National Radiological Protection Board. Medical exposure; guidance on the 1990 Recommendations of ICRP. Doc NRPB, 1993;4:2.
    • (1993) Doc NRPB , vol.4 , pp. 2
  • 7
    • 0025285816 scopus 로고
    • Excretion of iodine-123-hippuran, technetium-99m-red blood cells and technetium-99m-macroaggregated albumin into breast milk
    • Rose MR, Prescott MC, Herman KJ. Excretion of iodine-123-hippuran, technetium-99m-red blood cells and technetium-99m-macroaggregated albumin into breast milk. J Nucl Med 1990;31:978-84.
    • (1990) J Nucl Med , vol.31 , pp. 978-984
    • Rose, M.R.1    Prescott, M.C.2    Herman, K.J.3
  • 11
    • 0013592327 scopus 로고    scopus 로고
    • RCP guidelines on radiation protection following radioiodine therapy for thyrotoxicosis: Ar they appropriate?
    • abstract
    • Barrington SF, Kettle AG, Thomson WH, Burrell DN, Batchelor S, Mountford P, et al. RCP guidelines on radiation protection following radioiodine therapy for thyrotoxicosis: Ar they appropriate? Nucl Med Comm 1996;17:275 (abstract).
    • (1996) Nucl Med Comm , vol.17 , pp. 275
    • Barrington, S.F.1    Kettle, A.G.2    Thomson, W.H.3    Burrell, D.N.4    Batchelor, S.5    Mountford, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.